age annual hospital acute respiratory distress syndrome in-hospital mortality was 47%. Acute respiratory distress syndrome case volume was categorized as low (1) (2) (3) (4) (5) (6) (7) (8) (9) , medium , and high (50-423 cases per year). In a hospital-level Poisson regression adjusting for hospital characteristics, when compared with lowvolume acute respiratory distress syndrome hospitals, high-and medium-volume acute respiratory distress syndrome hospitals had lower annual acute respiratory distress syndrome case fatality (rate ratio, 0.75; 99% CI, 0.71-0.79 and rate ratio, 0.86; 99% CI, 0.82-0.90, respectively; p ≤ 0.001 for both). In an individual-level, multivariable model adjusting for hospital and individual characteristics, high and medium acute respiratory distress syndrome volume hospitals were associated with lower odds of acute respiratory distress syndrome mortality compared with low-volume hospitals (odds ratio, 0.85 [99% CI, 0.74-0.99]; p = 0.006 and odds ratio, 0.89 [99% CI 0.79-1.00]; p = 0.01, respectively). Conclusions: In this cohort, at both an individual-and hospitallevel, higher acute respiratory distress syndrome hospital case volume is associated with lower acute respiratory distress syndrome hospital mortality. (Crit Care Med 2018; 46:764-773) Key Words: adult; high-volume hospitals; low-volume hospitals; mortality; respiratory distress syndrome A cute respiratory distress syndrome (ARDS) is a severe inflammatory response in the lungs that follows an inciting injury, leading to hypoxic respiratory failure and often multiple organ failure and death. The actual incidence of ARDS in the United States is not completely understood, but two recent population-based studies have estimated the incidence between 40 and 80 cases per 100,000 personyears (1, 2) . The past few decades of translational research have demonstrated improved ARDS survival with specific lung protective mechanical ventilation strategies including low tidal volume ventilation, prone positioning, and use of neuromuscular blockade (1) (2) (3) (4) (5) (6) (7) . Given the highly coordinated and complex nature of these ARDS treatment strategies, one may postulate that institutional mastery requires knowledge, time, and ample frequency of patient experiences.
Although the volume-outcome relationship has not specifically been studied for ARDS, a recent meta-analysis has demonstrated associations between high annual volumes and improved outcomes among all critical care diagnoses (8) . However, among the 13 studies in this analysis that reported outcomes for respiratory diagnoses in critical care admissions, there was heterogeneity in the types of respiratory diagnoses examined, the categorization of annual hospital volumes, and the direction of volume-outcome relationships (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) .
We performed a retrospective review of the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample (NIS) administrative datasets from 2002 to 2011 and attempted to use a more specific case definition to approximate moderatesevere ARDS cases. The aim of this study is to examine the relationships between annual hospital ARDS case volumes and ARDS mortality. With this underlying conceptual framework, we hypothesized that hospitals with a higher annual volume of ARDS patients would demonstrate improved mortality outcomes.
METHODS

Data Source and Population
The NIS dataset contains detailed hospital discharge information and, for the years used, represents a stratified probability sample of American Hospital Association hospitals with sampling probabilities targeted to select 20% of the U.S. community hospitals (22) . With a study objective to explore an association in a large U.S. cohort rather than estimate national incidence, and an analytic plan to account for repeated measures in hospitals, the NIS stratified sampling design factors were not used in these analyses. The primary analysis includes all hospital discharge records between January 1, 2002, and December 31, 2011. We used a prior published ARDS case definition of records with International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) code 518.82 or 518.5 among any of the discharge diagnoses "plus" an accompanying ICD-9-CM procedure code for mechanical ventilation: 96.70, 96.71, or 96.72 (Table 1) (23) . Additionally, if the procedure code 96.71 was on the discharge record (mechanical ventilation < 96 hr duration), the patient also needed to be classified as deceased at discharge. This final stipulation was to create a study sample that most closely approximated moderate-severe ARDS, in which we hypothesize that experience and advanced therapies may have the most differential effect. This rationale is anchored on two landmark clinical studies that demonstrated that the 25th percentile of days of mechanical ventilation of survivors of moderate-severe ARDS ranges from 4 to 9 days (24, 25) . From this cohort, we excluded patients less than 18 years old, patients with a missing mortality status, and patients whose reason for admission was "birth."
Variables
The primary hospital-level outcome is a hospital's annual ARDS case fatality rate (CFR), and the primary individuallevel outcome is in-hospital mortality. The primary exposure of interest for both the individual-and hospital-level analyses is a hospital's annual ARDS case volume. Hospitals that recorded 1-9, 10-49, and 50-423 ARDS cases per year were categorized as "low," "medium," and "high" ARDS volume hospitals, respectively.
Statistical Analysis
Initial data management was performed using the SAS 9.4 (SAS Institute, Cary, NC). All graphical and statistical analyses were performed using RStudio 0.99.90. (RStudi, Boston, MA). The exploratory hospital-level analyses used a combination of qualitative graphical as well as descriptive statistics to categorize the annual ARDS volumes. Given that hospitals provided repeated years of data, we used random effects Poisson regression models that included hospital of discharge as a random effect for all bivariate associations. For multivariable models, we included, as fixed effects, variables that were associated with hospital ARDS CFR at a p value of less than 0.05 in bivariate Poisson regressions.
Individual-level analyses began with bivariate analyses by primary outcome and primary exposure. For bivariate analyses by individual mortality status, t tests, chi-square tests, and logistic regression were used. For bivariate analyses by hospital ARDS volume designation, analysis of variance (ANOVA), chi-square tests, and ordinal logistic regression were deployed. Two individual-level, fixed effects, multivariable models were explored: one a priori model with variables selected based on our prior hypotheses and a selected model with variables drawn from bivariate analyses results. For the selected individual-level model, covariates were selected from bivariate regression analyses as those with odds ratios (ORs) greater than or equal to 1.2 or less than or equal to 0.8 among any of the variable's response categories for both outcome and exposure. All of these selected variables were then retained in this individual-level model. By our design, both individual-level models included hospital of discharge as a fixed effect.
This study was declared exempt from review by the Emory University institutional review board given that the dataset is publically available, does not contain identifying information, and the data use agreement prohibits attempts of reidentification of persons. (26) . The codes "not included" in our case definition are "Acute Respiratory Failure, not otherwise specified" (518.81), "Chronic Respiratory Failure" (518.83), or "Acute and Chronic Respiratory Failure" (518.84). b For our primary case definition, if the discharge record contained this procedure code, the record also had to have a discharge condition as "deceased" to be included as a case.
RESULTS
Exploratory Hospital-Level Analysis
ARDS volume hospitals, the mean annual ARDS CFR was 51% (sd, 31%), 44% (sd, 14%), and 39% (sd, 9%), respectively (Fig. 1) .
In a simple Poisson regression model including hospital of discharge as a random effect, when compared with low ARDS volume hospitals, high and medium ARDS volume hospitals were significantly associated with lower annual ARDS CFRs (rate ratio [RR], 0.76; 99% CI, 0.76-0.84 and RR, 0.85; 99% CI, 0.85-0.93, respectively; p ≤ 0.001 for both). In a multivariable Poisson model including hospital of discharge as a random effect, and controlling for fixed effects of hospital region, overall bed size, urban/rural location, teaching status, ownership, mean Elixhauser score, and calendar year, hospitals with high and medium ARDS case volumes were associated with lower annual ARDS CFRs Our multivariable individual-level model constructed from bivariate analyses included the following fixed effects: hospital of discharge, teaching status, race, year, admission type, operating room procedure, primary payer, principle diagnosis category, all patient refined diagnosis related grouping (APR-DRG) mortality risk category, hospital urban/rural location, and hospital region. In this model, high and medium ARDS volume hospitals were associated with a lower odds of ARDS mortality compared with low ARDS volume hospitals (OR, 
Secondary Analyses
We performed a number of individual-level sensitivity analyses. First, we assessed different case definitions of ARDS. One alternative ARDS case definition used the same ICD-9-CM diagnosis and procedure codes as the primary definition but did not have the additional stipulation: "if procedure code 96.71 (continuous mechanical ventilation of < 96 hr) were specified, the candidate case must also have a vital status as deceased." The resultant cohort was larger, including 210,531 discharges, had a lower mortality at 22%, and we determined low-, medium-, and high-volume hospitals to be hospitals with 1-4, 5-14, and 15-799 cases annually. Using the aforementioned a priori multivariable model covariates, when compared with low-volume hospitals, high-and medium-volume centers were not associated with lower individual odds of hospital mortality (OR, 0.88 [99% CI, 0.71-1.10]; p =0.1 and OR, 1.04 [99% CI 0.86-1.25]; p = 0.6, respectively). A second alternative ARDS case definition used the same two ICD-9-CM diagnosis codes but without procedure codes. This cohort included 482,607 discharges with 16% hospital mortality, and we determined low-, medium-, and high-volume hospitals to be hospitals with 1-4, 5-49, and 50-2,243 cases annually. Using the aforementioned a priori multivariable model covariates, when compared with low-volume hospitals, high-but not medium-volume hospitals were associated with lower individual odds of hospital mortality (OR, 0.81 [99% CI, 0.65-1.01]; p = 0.01 and OR, 0.93 [99% CI, 0.75-1.14]; p = 0.4, respectively).
In addition to these sensitivity analyses, we explored two other relationships not part of our initial hypothesis. First, we assessed the interaction between patient severity of illness and the volume-outcome relationship using our principle ARDS case definition. We used the covariates from our "selected" model and included an interaction term between ARDS hospital volume and APR-DRG mortality risk category. There was a statistically significant difference in the model that included the interaction (ANOVA p < 0.001, Loess-smoothed curves in Fig. 2) . Second, we explored the interaction of the year of discharge on the volume-outcome association with the interaction model demonstrating a statistically significant difference (ANOVA, p < 0.001) (eFig. 6, Supplemental Digital Content 1, http://links.lww.com/CCM/D246). a. a Data plotted are individual predicted hospital mortality by acute respiratory distress syndrome (ARDS) case volume category among ARDS discharges. Adjustment covariates include hospital, hospital teaching status and individual, sex, year of discharge, expected primary payer, and all payer diagnosis-related group risk of mortality category, with an interaction term for risk category, and hospital ARDS volume category. Points correspond to each discharge's predicted mortality by the actual hospital case volume for that year while color signifies observations from different underlying risk of mortality categories. The curves were created using the Loess method of ggplot2 package. 
DISCUSSION
In this analysis of administrative hospital discharge data from a large U.S. cohort, we demonstrate associations of lower ARDS in-hospital mortality with higher annual ARDS case volume. First, at the unit of analysis of a hospital, higher annual hospital ARDS case volumes are associated with 0.75-0.86 relatively lower annual ARDS CFRs, even after adjusting for available hospital-level confounders. This relationship was preserved at the unit of analysis of the individual discharge. After controlling for available confounders, when compared with ARDS patients discharged from low-volume hospitals, individuals discharged from high-and medium-volume hospitals had a range of a 0.78-0.89 lower odds of mortality.
There are several factors to keep in mind when interpreting the results of this data. First, the long timespan and the large sample size increase strengthen the generalizability of the association. Second, our study attempts to address a more specifically defined ARDS case-volume relationship, whereas numerous other studies have explored more broad definitions of acute respiratory failure and mechanical ventilation volume (8-10, 12-17, 20) . However, our necessary reliance on an ICD-9-CM case definition may misclassify true cases of moderate-severe ARDS. Specifically, we recognize that while the disease process of interest is clinically defined moderatesevere ARDS, our case definition is at least three steps removed from this entity. First, the Berlin definition clinical criteria are not specific at identifying histologically defined ARDS (28). The APR-DRG risk of mortality and severity of illness subclass are assigned using a software developed and maintained by 3M Health Information Systems (www.hcup-us.ahrq.gov). Category of "minor loss of function" includes cases with no comorbidity or complication. c 11% of observations missing data on this variable. Second, clinicians often miss making the clinical diagnosis of ARDS (24) . Third, we hypothesize that further misclassification occurs from the clinical diagnosis to the ICD-9-CM coding on the discharge record. To make this final step even more complicated, while 518.5 and 518.82 are the only ICD-9-CM codes that include "ARDS as a synonym," there is no ICD-9-CM that is specifically "titled" as ARDS. Given these conditions, it is not possible to create a case definition that exactly matches our target population of moderate-severe ARDS.
Strengthening the construct validity of the case definition, we did not use codes for "Acute Respiratory Failure, not otherwise specified" (518.81), "Chronic Respiratory Failure" (518.83), or "Acute and Chronic Respiratory Failure" (518.84) and did use mechanical ventilation codes that attempted to approach a more severe population (23) . The observation that our hospital mortality of 47% is similar to the mortality of moderate and severe ARDS in clinical studies offers support to our case definition (24, 25) . An additional limitation is that we were unable to account for all relevant hospital-level factors (e.g., number of ICU beds, staffing models, individual provider volume) or individual-level factors (physiologic data for acute illness severity) leaving the potential for residual confounding.
In an attempt to explore some of the above limitations, we performed sensitivity analyses using two different, broader ICD-9-CM ARDS case definitions. These case definitions predictably produced larger cohorts with considerably lower average mortality rates with an attenuation of the volume-outcome relationship. For both of these analyses, there is attenuation of the associations at a variable level of significance, perhaps due to the capturing of many non-ARDS cases or lower severity cases.
These findings are novel, yet consistent with an existing body of literature that generally demonstrates improved outcomes among higher volume centers for many critical care diagnostic categories (8, 29) . Over the last several decades, numerous studies have strengthened the hypothesis that patients treated at high-volume centers have improved clinical outcomes, particularly among surgical and cardiac patients (30, 31) . However, in specific regard to respiratory diagnoses among the critically ill, a recent meta-analysis has demonstrated significant heterogeneity (8, 27) . Our study differs from these included studies in that it attempts to more specifically identify moderate-severe ARDS cases. In additions to exploring the volume-outcome relationship, the study also explores underlying patient mortality risk and calendar year of discharge on this volume-outcome association. In regard to underlying patient mortality risk, we make two graphical observations: 1) the volumeoutcome relationship has a consistent direction throughout all risk categories, yet 2) the slope of volume-outcome relationship varies by risk group and is steepest among those with a "major risk of death" and attenuated in those with either an "extreme risk of death" or a "minor risk of death." This effect modification supports the clinical intuition that patients with intermediate risk of dying may accrue the greatest benefits from care at an experienced high-volume center. Finally, in regard to the effect of time over the 2002-2011 study period, we see that the initial slope of the volume-outcome relationship remains stable, yet for each subsequent time-frame, there is a downward shift of the curve. This suggests that over the study period, there was a general downward trend in average ARDS mortality from 2002 to 2011.
Within the context of our study's strengths and limitations, the data suggest that both at a hospital-and individual-level, medium-and high-volume ARDS centers are associated with better ARDS outcomes, even after adjustments for available confounders. Furthermore, this association is sensitive to the underlying mortality risk of the ARDS population. The implications of our findings are clinically significant, particularly at a health systems level, in considering the regionalization of ARDS care. Regionalization involves the processes and infrastructure of routing and transferring ARDS patients from lowvolume hospitals to higher volume hospitals. Although our results generally lend support to regionalization for ARDS care during the study time period, it does not specifically address the question of whether routing or transfers of ARDS to higher volume centers can save lives. The rerouting and transferring of critically ill patients carries significant, potential risks and delays that may mitigate the generally higher performance of higher volume hospitals. Continued investigation of the impactful processes of high-performing hospitals and the risks and benefits of regionalization for ARDS is still needed to help clarify whether improving performances in lower volume hospitals or regionalization of care are more beneficial from individual and societal perspectives.
